Epirium Bio is a biotechnology company that is focused on developing treatments for rare genetic diseases. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts. Epirium Bio's lead product candidate is a gene therapy for the treatment of Pompe disease, a rare and debilitating genetic disorder that affects muscle function. The company is also developing gene therapies for other rare diseases, including Fabry disease and Gaucher disease. Epirium Bio is committed to advancing the field of gene therapy and improving the lives of patients with rare diseases.